Search

Your search keyword '"Maupain, C"' showing total 103 results

Search Constraints

Start Over You searched for: Author "Maupain, C" Remove constraint Author: "Maupain, C" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
103 results on '"Maupain, C"'

Search Results

1. Impact of diabetes on the management and outcomes in atrial fibrillation: an analysis from the ESC-EHRA EORP-AF Long-Term General Registry

2. Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry

6. Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry

7. Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry

8. Impact of renal impairment on atrial fibrillation

9. Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

10. Epidemiology and impact of frailty in patients with atrial fibrillation in Europe

11. Impact of diabetes on the management and outcomes in atrial fibrillation: an analysis from the ESC-EHRA EORP-AF Long-Term General Registry

12. Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation:a report from ESC-EHRA EORP-AF Long-Term General Registry

13. Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry

17. Prevalence and significance of atrial tachyarrhythmias in arrhythmogenic right ventricular cardiomyopathy

18. Authorization for athletes with a cardiomyopathy to participate in competitive or recreational sport: study of concordance within a panel of expert

21. P1480French experience of SICD implantation

22. 222AI-based strategy enables faster Holter ECG analysis with equivalent clinical accuracy compared to a classical strategy

24. QCM

26. Diagnostic value of additional right precordial leads both at rest and at peak stress test in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia (ARVC/D) patients

27. Psycho-social impact of predictive genetic testing in hereditary heart diseases (PREDICT Study)

29. Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Registry

30. P1018Evolution of atrioventricular conduction disorders after TAVI

32. P891Psycho-social impact of predictive genetic testing in hereditary heart diseases (PREDICT Study)

34. Outcomes after catheter ablation for treatment of electrical storm in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia

36. Contribution of electrophysiogical study for syncope in heart transplant patient: Retrospective analysis of 9 cases

37. L’hypogonadisme peut être un facteur de risque de torsade de pointes chez l’homme

39. 2116Outcomes after catheter ablation for treatment of electrical storm in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia

42. Does adenosine testing after second-generation cryoballoon ablation improve clinical success rate for paroxysmal atrial fibrillation?

44. P257Heart transplant patients with pacemaker: predictive factors for pacemaker requirement, for type of bradyarrhythmias, and prognostic factors for survival

45. The SAMe-TT2R2 score and quality of anticoagulation in atrial fibrillation:a simple aid to decision-making on who is suitable (or not) for vitamin K antagonists

46. The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: baseline data and contemporary management of adult patients with cardiomyopathies

47. Clinical course of arrhythmogenic right ventricular cardiomyopathy with end-stage heart failure and outcome after heart transplantation.

48. Evaluation of an Ambulatory ECG Analysis Platform Using Deep Neural Networks in Routine Clinical Practice.

49. Safety and efficacy of flecainide associated with beta-blockers in arrhythmogenic right ventricular cardiomyopathy.

50. External Validation of a Risk Prediction Model for Ventricular Arrhythmias in Arrhythmogenic Right Ventricular Cardiomyopathy.

Catalog

Books, media, physical & digital resources